Physician profile
Dechen Dolkar
NPI 1861475683
$1,421.53
in general payments reported to CMS, 2019-2025
19 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $357 · 2021: $21.47 · 2022: $112 · 2023: $56.67 · 2024: $60.62 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $729.55 | 2019-2020 | |
| Tesaro, INC. | $105.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $96.47 | 2023-2025 | |
| Siemens Medical Solutions USA, INC. | $70.70 | 2022 | |
| Brainlab, INC. | $65.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.59 | 2025 | |
| Caris Mpi, INC. | $39.89 | 2025 | Mi Cancer Seek |
| Karl Storz Endoscopy-America | $34.70 | 2020-2025 | Solo+ Ttd Handpiece |
| Incyte Corporation | $29.48 | 2023 | Monjuvi, Pemazyre |
| Stryker Corporation | $28.05 | 2025 | Spetzler-Malis, Nico Myriad Spectra |
| Boston Scientific Corporation | $26.21 | 2024 | Spaceoar Vue System - 10ml |
| Astrazeneca Pharmaceuticals LP | $23.34 | 2022 | |
| Amgen INC. | $21.47 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.62 | 2019 | |
| Merck Sharp & Dohme LLC | $18.11 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $17.30 | 2020 | |
| Aurobindo Pharma USA, INC. | $16.85 | 2019 | |
| Monteris Medical Corporation | $15.98 | 2019 | |
| Tactile Systems Technology INC | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dechen Dolkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.